The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
[EN] PROLYL HYDROXYLASE INHIBITORS<br/>[FR] INHIBITEURS DE PROLYLE HYDROXYLASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2007150011A3
公开(公告)日:2008-03-27
Prolyl Hydroxylase Inhibitors
申请人:GlaxoSmithKline, LLC
公开号:US20180305323A1
公开(公告)日:2018-10-25
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.